Skip to main content

Day: August 20, 2020

Tornado Global Hydrovacs Reports Second Quarter 2020 Results

CALGARY, Alberta, Aug. 20, 2020 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TGH: TSX-V) today reported its unaudited condensed consolidated financial results for the Three and Six Month periods ended June 30, 2020. The unaudited condensed consolidated financial statements and MD&A have been filed on SEDAR and can be reviewed at www.sedar.com and on the Company’s web site www.tornadotrucks.com. Financial and Operating Highlights (in CAD $000’s except per share data)1 Earnings (loss) before interest, tax, depreciation, amortization  and stock-based compensation (“EBITDAS”) and earnings (loss) before interest and tax (“EBIT”) are not defined by IFRS. The definition of EBITDAS does not consider gains and losses on the disposal of assets, fair value changes in foreign currency forward contracts...

Continue reading

VerifyMe and Corsearch to Collaborate on Positive Solutions for E-Commerce Counterfeiting and Brand Abuse

ROCHESTER, N.Y., Aug. 20, 2020 (GLOBE NEWSWIRE) — VerifyMe, Inc. (NASDAQ: VRME), a digital technology solutions provider specializing in brand protection functions such as; counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products, and Corsearch, Inc., a brand clearance and protection leader, are pleased to announce a collaboration that will support brands to reduce the global multi-billion dollar economic impact resulting from counterfeiting and piracy activities.The relationship will enhance enforcement capabilities for brands through the proactive identification and removal of unauthorized websites, domains, and products bearing the genuine intellectual property of legitimate companies.VerifyMe and Corsearch will work together to offer technologies and services that better...

Continue reading

Soluble Biotech Announces First Contract with a Major Pharmaceutical Company for Protein Expression and Solubility Studies

EAGAN, Minn., Aug. 20, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to announce that its Soluble Biotech division, a provider of soluble and stable formulations for proteins, just received its first substantial contract from a major pharmaceutical company since being acquired by Predictive Oncology in May 2020. The project involves protein expression followed by solubility studies, areas of significant expertise within Soluble Biotech.“Our first contract is a major milestone and validates our recent move into a new, larger facility”, says Dr. Larry DeLucas, former NASA astronaut and founder of Soluble Biotech. “We quadrupled our laboratory and office space, some of which will eventually...

Continue reading

Aequus Announces New Chief Commercial Officer

VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to welcome Grant Larsen to the Aequus Team as Chief Commercial Officer, beginning August 17th, 2020.Mr. Larsen brings almost 20 years of senior management positions in North American Eyecare. His in-depth knowledge of Canadian Optometry, direct to consumer marketing, online technology and medical devices, brings important experience to accelerate growth for Aequus’ expanding portfolio of products. Mr. Larsen has a strong background in strategic leadership, most recently as the past CEO of Eye Recommend, one of Canada’s largest cooperatives of optometrists. In addition,...

Continue reading

AMMO, Inc. Reports Fiscal First Quarter 2021 Results

– Fiscal First Quarter 2021 Revenue Increases 125% to $9.7 Million –– Largest Backlog in Company History Increases to $45 Million –SCOTTSDALE, Ariz., Aug. 20, 2020 (GLOBE NEWSWIRE) — AMMO, Inc. (OTCQB: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, has reported financial results for its fiscal first quarter ended June 30, 2020.Financial Summary for Fiscal First Quarter 2021 vs. Fiscal First Quarter 2020Total revenue increased 125% to $9.7 million compared to $4.3 million.º Proprietary ammunition revenue increased 856% to $1.9 million.º Standard ammunition revenue increased 379% to $4.5 million.º Casing revenue increased 3% to $3.2 million.Net loss improved to $3.1 million compared to a net loss of $3.8 million.Adjusted EBITDA improved to $(0.3) million compared...

Continue reading

Interpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on Listing

PARSIPPANY, NJ, Aug. 20, 2020 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) on August 18, 2020 received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the delay in the filing of the Company’s Form 10-Q for the quarterly period ended June 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), Interpace does not currently satisfy Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all periodic reports with the SEC. The deficiency has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.In accordance with the Nasdaq Listing Rules, Interpace was provided 60 calendar days to submit its plan to evidence compliance with the filing requirement...

Continue reading

Fejl i indre værdi i Kapitalforeningen BLS Invest

Det kan oplyses, at der i perioden fra 19. august ca. kl. 10.13 til 20. august ca. kl. 09.30 har været fejl i indre værdi i afdelingen Danske aktier akk. (ISIN DK0061143260). Fejlen har gjort at afdelingernes indre værdi har været overvurderet med 0,9%.Afsluttende kan det oplyses, at børsmæglerforeningen er orienteret herom. Eventuel henvendelse vedrørende denne meddelelse kan rettes til afdelingsdirektør Lars Aasand, tlf. 44 55 86 87.Med venlig hilsenKapitalforeningen BLS Invest

Continue reading

Ayala Pharmaceuticals Announces the Appointment of Vered Bisker-Leib, Ph.D. To Its Board of Directors

REHOVOT, Israel and WILMINGTON, Del., Aug. 20, 2020 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA) (the Company or Ayala), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced the appointment of Vered Bisker-Leib, Ph.D., to its Board of Directors, joining as a member of the Audit and Compensation Committees.“Vered is a significant addition to our Board of Directors as we continue to grow Ayala as a public company and we are thrilled to be able to tap into her deep strategic, operational and financial expertise,” said Roni Mamluk, Ph.D., Chief Executive Officer of Ayala. “Through her leadership and strategic experience gained as Chief Operating...

Continue reading

Duluth Holdings Announces Grand Opening of its 64th Store in Orland Park, Illinois

MOUNT HOREB, Wis., Aug. 20, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced the Grand Opening of its 64th store in Orland Park, Illinois.  The Orland Park store is located at 29 Orland Square Drive, Orland Park, IL 60462.“We are excited to open our third Duluth Trading store in the Chicago metro area,” said Steve Schlecht, Executive Chairman and Chief Executive Officer of Duluth Trading. “Duluth Trading fans around Chicago have been shopping with us for years, and now they have a new location convenient to the south suburbs.  We are delighted that our loyal customers can now enjoy three ways to shop – in-store, curbside and online—to experience our innovative solution-based apparel...

Continue reading

Siyata Mobile Aligns with Vive Wireless and Receives Initial Purchase Order

MONTRÉAL, Aug. 20, 2020 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF/ FRA: WK3D) is pleased to announce the Company has aligned with Vive Wireless, an Authorized Wireless Bell Dealer in Canada, to engage in multiple opportunities for the Uniden UV350 in conjunction with an initial purchase order from a leading Canadian construction company through Vive Wireless.Marc Seelenfreund, CEO of Siyata Mobile states, “We are very pleased to align ourselves with Vive Wireless as part of our objective to become a leading vendor of innovative cellular devices for enterprise customers in North America. This is the third leading Canadian construction company this year that has opted to move from their antiquated land mobile radio systems and upgrade to our innovative Push-to-Talk over Cellular based UV350 which we believe provides...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.